Nontuberculous Mycobacterial Lung Disease
Symptoms, Doctors, Treatments, Advances & More

Nontuberculous Mycobacterial Lung Disease Overview

Save information for later
Sign Up

Learn About Nontuberculous Mycobacterial Lung Disease

What is the definition of Nontuberculous Mycobacterial Lung Disease?
Nontuberculous mycobacterial lung disease is a non-contagious, non-tuberculosis infection caused by bacteria commonly found in water and soil. The disease can also affect other areas of the body, such as the skin, bones, and lymph nodes. Nontuberculous mycobacterial lung disease more commonly affects people with compromised immune systems and pre-existing lung disease, such as chronic obstructive pulmonary disease and cystic fibrosis.
What are the symptoms of Nontuberculous Mycobacterial Lung Disease?
A person infected with nontuberculous mycobacterial lung disease may have no symptoms or only mild symptoms. Other symptoms of nontuberculous mycobacterial lung disease may include shortness of breath, chronic cough, coughing up sputum, coughing up blood, wheezing, chest pain, recurrent respiratory infections, anxiety, weakness, fatigue, fever, rashes, swollen lymph nodes, night sweats, loss of appetite, diarrhea, and unexplained weight loss.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Nontuberculous Mycobacterial Lung Disease?
Treatment for nontuberculous mycobacterial lung disease may include watchful waiting; respiratory therapy, such as nebulizers, to clear airways; amikacin liposome inhalation suspension; antiviral medications; and antibiotics. In rare instances, surgery may be needed to remove an infected portion of the lung.
Who are the top Nontuberculous Mycobacterial Lung Disease Local Doctors?
Elite in Nontuberculous Mycobacterial Lung Disease
Dr. Timothy Aksamit
Intensive Care Medicine
Elite in Nontuberculous Mycobacterial Lung Disease
Dr. Timothy Aksamit
Intensive Care Medicine
Referral may be required

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
757-490-4802
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Timothy Aksamit is an Intensive Care Medicine provider practicing medicine in Virginia Beach, Virginia. Dr. Aksamit is rated as an Elite provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Bronchiectasis, Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex Infections, and Chronic Obstructive Pulmonary Disease (COPD).

Elite in Nontuberculous Mycobacterial Lung Disease
Dr. Edward Chan
Intensive Care Medicine
Elite in Nontuberculous Mycobacterial Lung Disease
Dr. Edward Chan
Intensive Care Medicine
Referral may be required

Denver Veterans Administration

1055 Clermont St, 
Denver, CO 
303-399-8020
Languages Spoken:
English
See accepted insurances

Edward Chan is an Intensive Care Medicine provider practicing medicine in Denver, Colorado. Dr. Chan is rated as an Elite provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex Infections, Pectus Excavatum, and Bronchiectasis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Nontuberculous Mycobacterial Lung Disease
Dr. Kevin Winthrop
Internal Medicine
Elite in Nontuberculous Mycobacterial Lung Disease
Dr. Kevin Winthrop
Internal Medicine

OHSU Hospital

3181 SW Sam Jackson Park Rd, 
Portland, OR 
503-494-4971
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kevin Winthrop is an Internal Medicine provider practicing medicine in Portland, Oregon. Dr. Winthrop is rated as an Elite provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Mycobacterium Avium Complex Infections, Shingles, Nontuberculous Mycobacterial Lung Disease, COVID-19, and Cataract Removal.

View All Doctors
What are the latest Nontuberculous Mycobacterial Lung Disease Clinical Trials?
A Randomized Controlled Trial of Early Versus Delayed Hypertonic Saline Inhalation in Treatment-Naïve Nontuberculous Mycobacterial Lung Disease
A Randomized Controlled Trial of Early Versus Delayed Hypertonic Saline Inhalation in Treatment-Naïve Nontuberculous Mycobacterial Lung Disease
Enrollment Status: Recruiting
Publish Date: June 15, 2026
Intervention Type: Drug
Study Phase: Not Applicable

Summary: This multicenter randomized controlled trial evaluates the clinical and microbiological effects of inhaled 3% hypertonic saline in treatment-naïve patients with nontuberculous mycobacterial lung disease (NTM-LD). Participants are randomized in a 1:1 ratio to either early initiation of 3% hypertonic saline for 6 months or delayed initiation consisting of normal saline inhalation during the first 3 ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Validation of Soluble Programmed Death-1 in Predicting Progression of Nodular-bronchiectatic Form of Nontuberculous Mycobacterial Lung Disease: a Multi-Country Research
Validation of Soluble Programmed Death-1 in Predicting Progression of Nodular-bronchiectatic Form of Nontuberculous Mycobacterial Lung Disease: a Multi-Country Research
Enrollment Status: Recruiting
Publish Date: June 10, 2026

Summary: The incidence of nontuberculous mycobacterial lung disease (NTM-LD) is increasing worldwide and in Eastern Asia. NTM-LD leads significant morbidity and mortality, around 25% within 5 years, but the treatment rate is low because the course of NTM-LD is indolent, especially in nodular-bronchiectatic (NB) form. However, there is no biomarker proven for predicting the progression in NB form of NTM-LD....

View All Clinical Trials